Is Orchestra BioMed Holdings, Inc. overvalued?

Orchestra BioMed Holdings, Inc. (OBIO) — key valuation metrics and fundamentals.

No verdict

Price

$4.41

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$264.1M

Dividend yield

0.0%

Return on equity

-133.1%

Sector

Healthcare

Fair value compares OBIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks